Active

BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Financials

KRS
0000966576Copy
Copy
REGON
521771464Copy
Copy
NIP
6412557695Copy
Copy
Registered address
UL. LUDOWA 7, 41-300, DĄBROWA GÓRNICZA, POLSKA
Registered
14/04/2022

Company overview

Status
Active
Latest financial data
2024
Available financial years
2022–2024
VAT status
Active

Financial highlights

Key financial results based on available financial statements for 2022–2024.

Turnover

5,400 zł2024
-63%vs 2023

2023: 14,498 zł

Profit before tax

2,345 zł2024
-2%vs 2023

2023: 2,387 zł

Net Profit

2,134 zł2024
8%vs 2023

2023: 1,971 zł

Equity

41,028 zł2024
5%vs 2023

2023: 38,894 zł

In 2024, BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ reported turnover of 5,400 zł. Other key financial indicators include profit before tax of 2,345 zł, net profit of 2,134 zł, and equity of 41,028 zł. Current liabilities fell from 68,304 zł in 2023 to 58,435 zł in 2024 (-14%). Detailed financial data for 2022–2024 is available in the table below. View financial data by year.

Financial performance

Select a financial indicator to view its historical performance and annual changes.

Turnover

5,400 zł2024
-63%from 14,498 zł in 2023

Annual change

Turnover as filed for 2022–2024. Every figure in this chart is also in the financial history table.

Financial trends over 3 years (2022–2024)

See how the company’s financial results changed over the reported years 2022–2024. Compare annual figures and identify the biggest increases and decreases.

Turnover

Turnover by year, 2022 to 2024, with the change from the previous year
YearValueChange vs previous year
20220 zł
202314,498 złIncreased
20245,400 zł-62.8%
Total change (2022–2024)Increased

Profit before tax

Profit before tax by year, 2022 to 2024, with the change from the previous year
YearValueChange vs previous year
2022-3,077 zł
20232,387 złIncreased
20242,345 zł-1.8%
Total change (2022–2024)Increased

Net Profit

Net Profit by year, 2022 to 2024, with the change from the previous year
YearValueChange vs previous year
2022-3,077 zł
20231,971 złIncreased
20242,134 zł+8.3%
Total change (2022–2024)Increased

Equity

Biggest rise
Equity by year, 2022 to 2024, with the change from the previous year
YearValueChange vs previous year
202236,924 zł
202338,894 zł+5.3%
202441,028 zł+5.5%
Total change (2022–2024)+11.1%

+5.4% a year (CAGR)

Financial ratios

Explore key financial ratios to better understand the company’s financial position and performance.

Net profitability
39.52%2024
Working capital requirement (%)
7.602024
Liquidity ratio
1.702024
liquidityRatio

Financial history

Explore the company’s financial data over the years and compare historical results.

Financial data for BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ, based on available financial statements. A dash (–) indicates that data for the selected year is unavailable.

Indicator202220232024
Turnoverzł014,4985,400
Profit before taxzł-3,0772,3872,345
Net Profitzł-3,0771,9712,134
Equityzł36,92438,89441,028
Current liabilitieszł22,67868,30458,435
Non current liabilitieszł0––
Non-current Assetszł0––

BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ financials: frequently asked questions

Answers based on BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ’s available financial data.

Yes. Okredo holds filed figures for BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ covering 2022–2024, across 7 reported indicators. The most recent reported year is 2024.

BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ reported turnover of 5,400 zł for 2024. That compares with 14,498 zł in 2023, a change of -63%.

BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ reported profit before tax of 2,345 zł for 2024. That compares with 2,387 zł in 2023, a change of -2%.

BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ reported net profit of 2,134 zł for 2024. That compares with 1,971 zł in 2023, a change of 8%.

Explore how 4 financial indicators changed for BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ between 2022 and 2024. The largest increase was in Equity, at +11.1%. The compound annual growth rate of Equity was +5.4% over the period.

Financial data is available for 2022, 2023, and 2024. A dash (–) in the financial history table indicates unavailable data.